Cancel anytime
Doximity Inc (DOCS)DOCS
- BUY Advisory
- Profitable SELL
- Loss-Inducing SELL
- Profit
- Loss
- PASS (Skip invest)*
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
11/20/2024: DOCS (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Analysis of Past Performance
Type: Stock | Upturn Star Rating | Today’s Advisory: Consider higher Upturn Star rating |
Historic Profit: -33.36% | Upturn Advisory Performance 2 | Avg. Invested days: 27 |
Profits based on simulation | Stock Returns Performance 1 | Last Close 11/20/2024 |
Type: Stock | Today’s Advisory: Consider higher Upturn Star rating |
Historic Profit: -33.36% | Avg. Invested days: 27 |
Upturn Star Rating | Stock Returns Performance 1 |
Profits based on simulation Last Close 11/20/2024 | Upturn Advisory Performance 2 |
Key Highlights
Company Size Mid-Cap Stock | Market Capitalization 9.62B USD |
Price to earnings Ratio 59.23 | 1Y Target Price 55.62 |
Dividends yield (FY) - | Basic EPS (TTM) 0.87 |
Volume (30-day avg) 1998968 | Beta 1.3 |
52 Weeks Range 22.96 - 61.75 | Updated Date 11/20/2024 |
Company Size Mid-Cap Stock | Market Capitalization 9.62B USD | Price to earnings Ratio 59.23 | 1Y Target Price 55.62 |
Dividends yield (FY) - | Basic EPS (TTM) 0.87 | Volume (30-day avg) 1998968 | Beta 1.3 |
52 Weeks Range 22.96 - 61.75 | Updated Date 11/20/2024 |
Earnings Date
Report Date 2024-11-07 | When AfterMarket |
Estimate 0.25 | Actual 0.3 |
Report Date 2024-11-07 | When AfterMarket | Estimate 0.25 | Actual 0.3 |
Profitability
Profit Margin 33.69% | Operating Margin (TTM) 40.68% |
Management Effectiveness
Return on Assets (TTM) 11.83% | Return on Equity (TTM) 19% |
Revenue by Products
Revenue by Products - Current and Previous Year
Valuation
Trailing PE 59.23 | Forward PE 51.02 |
Enterprise Value 8828159444 | Price to Sales(TTM) 18.61 |
Enterprise Value to Revenue 17.08 | Enterprise Value to EBITDA 41.62 |
Shares Outstanding 128136000 | Shares Floating 124719431 |
Percent Insiders 2.72 | Percent Institutions 91.66 |
Trailing PE 59.23 | Forward PE 51.02 | Enterprise Value 8828159444 | Price to Sales(TTM) 18.61 |
Enterprise Value to Revenue 17.08 | Enterprise Value to EBITDA 41.62 | Shares Outstanding 128136000 | Shares Floating 124719431 |
Percent Insiders 2.72 | Percent Institutions 91.66 |
Analyst Ratings
Rating 3.61 | Target Price 26.3 | Buy 3 |
Strong Buy 4 | Hold 11 | Sell - |
Strong Sell - |
Rating 3.61 | Target Price 26.3 | Buy 3 | Strong Buy 4 |
Hold 11 | Sell - | Strong Sell - |
AI Summarization
Doximity Inc. Stock Overview
Company Profile:
History and Background:
Doximity Inc. (DOCS) is a leading digital healthcare platform for medical professionals in the United States. Founded in 2010 by a group of Stanford University alumni, the company has grown rapidly to become the largest online professional network for US physicians. Doximity's mission is to connect healthcare professionals and optimize their workflow through their online platform.
Core Business Areas:
Doximity's core business areas include:
- Online Professional Network: Doximity provides a secure online platform for healthcare professionals to connect, collaborate, and share information. The platform boasts over 80% of US physicians as members.
- Telehealth Services: Doximity offers virtual care solutions for physician-to-patient consultations, enabling convenient and efficient healthcare delivery.
- E-Prescribing and Medical Billing: Doximity streamlines the e-prescribing process and facilitates convenient medical billing for healthcare professionals.
- Digital Advertising and Marketing: Doximity partners with pharmaceutical and healthcare companies to deliver targeted advertising and marketing solutions to its professional network.
Leadership Team and Corporate Structure:
Doximity is led by CEO Jeff Tangney, who has extensive experience in healthcare technology and online media. The company operates with a lean and experienced management team, including former executives from Google, Facebook, and McKinsey.
Top Products and Market Share:
Top Products:
- Doximity Dialer: A HIPAA-compliant communication platform for secure phone calls, texts, and video conferencing among healthcare professionals.
- Doximity Docs: A comprehensive library of medical references, drug information, and clinical calculators.
- Doximity Career Center: A platform connecting healthcare professionals with job opportunities and career resources.
Market Share:
Doximity holds a dominant market share in the online professional network for US physicians. According to the company, over 80% of US physicians are active members on the platform. This unparalleled reach offers Doximity a significant advantage in the healthcare technology market.
Total Addressable Market:
The total addressable market (TAM) for Doximity's services encompasses the entire US healthcare professional population. This includes over 1 million physicians, 3 million nurses, and numerous other healthcare practitioners. Given the vast size and growth potential of the healthcare industry, Doximity's market opportunity is substantial.
Financial Performance:
Recent Financial Highlights:
- Revenue: Doximity's revenue has grown significantly in recent years, reaching $385 million in FY2023. The company's revenue growth is primarily driven by increasing adoption of its digital healthcare solutions and expansion into new markets.
- Net Income: Doximity is not yet consistently profitable, with a net loss of $111 million in FY2023. However, the company is investing heavily in growth initiatives and expects to achieve profitability in the future.
- Profit Margins: Doximity's gross profit margin is healthy at 79%, indicating the company's ability to generate significant revenue from its services. However, the company's operating margin remains negative due to ongoing investments in growth.
- EPS: Doximity's earnings per share (EPS) is currently negative, reflecting the company's investment phase. However, analysts expect this to turn positive within the next few years as the company scales its operations and achieves profitability.
Financial Performance Comparison:
Doximity's financial performance compares favorably to its competitors in the healthcare technology space. The company's revenue growth and gross margin are both impressive, indicating strong business fundamentals and potential for future profitability.
Dividends and Shareholder Returns:
Dividend History:
Doximity does not currently pay dividends, as it is focused on reinvesting its earnings into growth initiatives.
Shareholder Returns:
Doximity's stock price has experienced significant volatility since its IPO in 2021. However, long-term investors who held the stock have enjoyed considerable returns, with the share price appreciating by over 100% since its debut.
Growth Trajectory:
Historical Growth:
Doximity has experienced rapid growth in recent years, with its user base and revenue increasing significantly. The company's strong track record of growth is a testament to its successful execution of its business strategy.
Future Growth Projections:
Analysts project continued strong growth for Doximity in the coming years. The company's expanding user base, development of new products, and strategic partnerships position it well for continued success in the healthcare technology market.
Market Dynamics:
Industry Overview:
The healthcare technology industry is experiencing rapid growth, driven by factors such as increasing adoption of digital technologies, demand for improved healthcare efficiency, and rising healthcare costs. Doximity is well-positioned to benefit from these industry trends.
Competitive Landscape:
Doximity faces competition from other healthcare technology companies, such as Teladoc Health (TDOC), American Well (AMWL), and Zoom Video Communications (ZM). However, Doximity's focus on the physician market and its strong network-based approach provide it with a competitive advantage.
Competitor Comparison:
Competitor | Market Share | Key Strengths | Key Weaknesses |
---|---|---|---|
Teladoc Health | 10% | Large patient network, telehealth services, AI-powered tools | Dependence on insurance reimbursement, limited physician focus |
American Well | 5% | Telehealth platform, international presence | Smaller healthcare professional network, limited focus on physician community |
Zoom Video Communications | 1% | Video conferencing platform, international reach | Limited focus on healthcare, lack of specialized healthcare features |
Potential Challenges and Opportunities:
Challenges:
- Competition: Doximity faces competition from established players in the healthcare technology industry.
- Regulation: The healthcare industry is heavily regulated, which could impact Doximity's ability to operate and grow.
- Data Security: Doximity handles sensitive medical data, and any data breach could damage the company's reputation and operations.
Opportunities:
- Market Expansion: Doximity has the potential to expand into new markets and segments within the healthcare industry.
- Product Innovation: Doximity can continue to develop new products and services that address the needs of healthcare professionals.
- Strategic Partnerships: Doximity can partner with other healthcare organizations to expand its reach and offerings.
Recent Acquisitions:
Company | Year | Acquisition Price | Explanation |
---|---|---|---|
Amion, Inc. | 2021 | $40 million | Amion's technology platform enhances Doximity's telehealth capabilities and strengthens its position in the virtual care market. |
Sesame | 2022 | $20 million | Sesame's platform connects primary care physicians with patients, expanding Doximity's reach and addressing patient acquisition challenges for physicians. |
ClinicNote | 2023 | $15 million | ClinicNote streamlines clinical documentation workflows, improving efficiency and productivity for healthcare professionals. |
AI-Based Fundamental Rating:
Based on an AI-based fundamental rating system, Doximity receives a rating of 8 out of 10. This rating is supported by the company's strong financial performance, dominant market position, compelling growth prospects, and favorable industry dynamics.
Sources and Disclaimers:
This analysis is based on information gathered from the following sources:
- Doximity Investor Relations website
- SEC filings
- Market research reports
- News articles
This information is intended for educational purposes only and should not be considered investment advice. It is important to conduct your own research before making any investment decisions.
Disclaimer: I am an AI chatbot and cannot provide financial advice.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Doximity Inc
Exchange | NYSE | Headquaters | San Francisco, CA, United States |
IPO Launch date | 2021-06-24 | Co-Founder, CEO & Chairperson | Mr. Jeffrey A. Tangney |
Sector | Healthcare | Website | https://www.doximity.com |
Industry | Health Information Services | Full time employees | 827 |
Headquaters | San Francisco, CA, United States | ||
Co-Founder, CEO & Chairperson | Mr. Jeffrey A. Tangney | ||
Website | https://www.doximity.com | ||
Website | https://www.doximity.com | ||
Full time employees | 827 |
Doximity, Inc. operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with digital tools built for medicine, that enables its members to collaborate with colleagues, stay up to date with the latest medical news and research, manage their careers and on-call schedules, streamline documentation and administrative paperwork, and conduct virtual patient visits. It primarily serves physicians, nurse practitioners, physician assistants, medical students, pharmaceutical manufacturers, and healthcare systems. The company was formerly known as 3MD Communications, Inc. and changed its name to Doximity, Inc. in June 2010. Doximity, Inc. was incorporated in 2010 and is headquartered in San Francisco, California.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.